gallstones glp 1 GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications Gallbladder Risks with GLP-1 Medications

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

manufactured in cGMP-certified facilities, third-party tested for purity, and non-GMO, gluten-free, with zero artificial additives or fillers

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds.

Orforglipron an oral GLP-1 drug in development, is being studied for weight loss and diabetes

Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved for treating type 2 diabetes and weight loss

Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers